Ethyl pyruvate preserves IGF-I sensitivity toward mTOR substrates and protein synthesis in C2C12 myotubes

Robert A Frost1, Erika Pereyra, Charles H Lang

  • 1Department of Cellular and Molecular Physiology (H166), Pennsylvania State University College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, USA. rfrost@psu.edu

Endocrinology
|November 26, 2010
PubMed

Insights

Bacterial infection impairs muscle protein synthesis by inhibiting mTOR signaling. Lipophilic pyruvate derivatives and antioxidants can restore mTOR activity and muscle protein synthesis by maintaining IGF-I sensitivity.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Biology

Background:

  • Bacterial infections disrupt skeletal muscle protein synthesis by inhibiting the mammalian target of rapamycin (mTOR) pathway.
  • Understanding the precise mechanisms of mTOR inhibition is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate how bacterial endotoxins and cytokines inhibit mTOR signaling in muscle cells.
  • To determine if lipophilic pyruvate derivatives can restore mTOR signaling and protein synthesis.

Main Methods:

  • C2C12 myotubes were treated with lipopolysaccharide (LPS) and interferon-gamma (IFN-γ) to mimic bacterial infection effects.
  • Assessed mTOR signaling by measuring phosphorylation of key substrates like S6 kinase-1 and 4E-binding protein-1.
  • Evaluated the impact of methyl pyruvate, ethyl pyruvate, and antioxidants on mTOR activity and insulin-like growth factor-I (IGF-I) sensitivity.

Main Results:

  • LPS/IFN-γ treatment significantly reduced protein synthesis and mTOR signaling, affecting both translation initiation and elongation.
  • Ethyl and methyl pyruvate partially protected against mTOR inhibition, with ethyl pyruvate showing a more pronounced effect.
  • Prolonged LPS/IFN-γ exposure induced IGF-I resistance at the mTOR level, which was reversed by ethyl pyruvate and antioxidants.
  • Antioxidants like N-acetyl cysteine and ascorbic acid also preserved mTOR activity and IGF-I sensitivity.

Conclusions:

  • Bacterial infection components (LPS/IFN-γ) inhibit mTOR signaling and induce IGF-I resistance in skeletal muscle cells.
  • Lipophilic pyruvate derivatives, particularly ethyl pyruvate, and antioxidants show potential in restoring mTOR activity and protein synthesis by maintaining IGF-I sensitivity.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Fates of Pyruvate01:20

Fates of Pyruvate

Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...